logo-loader
viewBioasis Technologies Inc.

Bioasis Technologies secures patents in key global markets

Bioasis Technologies, Inc . (OTCQB:BIOAF) (CVE:BTI) CEO Deborah Rathjen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Guilford, Connecticut-based company is developing a proprietary technology to delivery therapeutics across the blood brain barrier and treating CNS disorders in brain cancers and neurodegenerative diseases.

Quick facts: Bioasis Technologies Inc.

Price: 0.1591 USD

OTCQB:BIOAF
Market: OTCQB
Market Cap: $10.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks finish week in the red; Canaccord initiates...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was down 2.6% higher at 117.4 points. Elsewhere, the OTCQX Cannabis index fell 1.8% to 480.1 points. Buds today were Pharmacielo Ltd (CVE:PCLO), The Valens Company (CVE:VLNS) (OTCMKTS:VLNCF)....

2 hours, 40 minutes ago

2 min read